Teriparatide
Bonsity, Forteo
Parathyroid Hormone Analog
NADAC/unit
$595.5376
No Shortage
Tier 1: 28.3%
PA Req: 143.5%
3 Manufacturers
3 ANDAs
indicated: For the treatment of postmenopausal women with osteoporosis at high risk for fracture (defined herein as having a history of osteoporotic fracture or multiple risk factors for fracture) ....
vs. brand Bonsity: Generic saves up to -5855% per unit
Generic Manufacturers
ALMAJECT INCALVOGEN INCAMPHASTAR PHARMACEUTICALS INCAPOTEX INCELI LILLY AND COTEVA PHARMACEUTICALS USA INC
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.
